Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Merck
Farmers Insurance
Accenture
Baxter
Johnson and Johnson
Boehringer Ingelheim
Cantor Fitzgerald
Medtronic

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,809,305

« Back to Dashboard

Summary for Patent: 8,809,305
Title:Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Abstract: A regimen for the safe and effective long-term treatment of acne vulgaris entails topically applying onto the affected skin area of a subject afflicted therewith, for a period of time of at least four (4) months, e.g., for at least twelve (12) months and advantageously on a daily basis and preferably once a day, a thus effective amount of a topical medicament containing adapalene and benzoyl peroxide, formulated into a pharmaceutically acceptable medium therefor.
Inventor(s): Graeber; Michael (Lawrenceville, NJ), Liu; Yin (Princeton Junction, NJ), Gore; Barbara (Cranbury, NJ)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:12/458,982
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,809,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF ACNE ➤ Subscribe
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF ACNE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,809,305

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 2114392 ➤ Subscribe
Russian Federation 2481832 ➤ Subscribe
Russian Federation 2009132502 ➤ Subscribe
Portugal 2114392 ➤ Subscribe
Japan 2011510907 ➤ Subscribe
Hungary E025484 ➤ Subscribe
Croatia P20150940 ➤ Subscribe
Spain 2546029 ➤ Subscribe
European Patent Office 2114392 ➤ Subscribe
Denmark 2114392 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Cantor Fitzgerald
Baxter
Harvard Business School
Moodys
Mallinckrodt
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot